Adial Pharmaceuticals, Inc. Adjustments to Additional Paid in Capital, Other
Adial Pharmaceuticals, Inc. (ADIL) reported Adjustments to Additional Paid in Capital, Other of $4.46 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2026-03-05
- Adial Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2024-03-31 was $4.46M, a 632.34% increase year-over-year.
- Adial Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2023-03-31 was $609.61K, a 93.32% decline year-over-year.
- Adial Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2022-03-31 was $9.12M.
- Adial Pharmaceuticals, Inc. adjustments to additional paid in capital, other for the quarter ending 2018-06-30 was $222.95K.
- Adial Pharmaceuticals, Inc. adjustments to additional paid in capital, other for fiscal 2024 was $4.46M, a 495.30% increase from fiscal 2023.
- Adial Pharmaceuticals, Inc. adjustments to additional paid in capital, other for fiscal 2023 was $749.94K, a 91.78% decline from fiscal 2022.
- Adial Pharmaceuticals, Inc. adjustments to additional paid in capital, other for fiscal 2022 was $9.12M.
- Adial Pharmaceuticals, Inc. adjustments to additional paid in capital, other for fiscal 2018 was $222.95K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|
| 2024-12-31 | $4.46M 10-K · filed 2026-03-05 | |
| 2024-03-31 | $4.46M 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $749.94K 10-K · filed 2024-04-01 | |
| 2023-03-31 | $609.61K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $9.12M 10-K · filed 2024-04-01 | |
| 2022-03-31 | $9.12M 10-Q · filed 2023-11-14 | |
| 2018-12-31 | $222.95K 10-K · filed 2020-03-20 | |
| 2018-06-30 | $222.95K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |